ALMS

AS OF

Dec 24 closing price

Price

$11.40

Change

-$0.05 (-0.44%)

Capitalization

1.19B

90 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

ALMS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Alumis (ALMS) Ownership - Who owns Alumis?

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

ALMS

Capitalization

1.19B

P/E Ratio

0.17

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

378M

Total Cash/Share

3.62

Total Debt

37.8M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.31%

Revenue

22.1M

ROE

N/A

Book Value

385M

P/B Ratio

3.09

Cash Flow

N/A

Earnings

-2.15

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

10K

Current Ratio

6.01

Current Revenue Per Employee

8866.95

Dividends Per Share - Security

N/A

EBITDA

-452.53M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-54.44

Shares Held By Institutions

300M

Shares Outstanding - Current

104M

Total Liabilities

103M

Total Volume MTD

N/A

Value

Gain YTD

45.038

View a ticker or compare two or three

Compare

ALMS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.

View AI-Driven Trading for ALMS

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details